Diverse macrophage populations contribute to distinct manifestations of human cutaneous graft-versus-host disease.


Journal

The British journal of dermatology
ISSN: 1365-2133
Titre abrégé: Br J Dermatol
Pays: England
ID NLM: 0004041

Informations de publication

Date de publication:
27 Nov 2023
Historique:
received: 07 07 2023
revised: 01 10 2023
accepted: 04 10 2023
medline: 27 11 2023
pubmed: 27 11 2023
entrez: 27 11 2023
Statut: aheadofprint

Résumé

Graft-versus-host disease (GvHD) is a major life-threatening complication of allogeneic haematopoietic stem cell transplantation (HSCT), limiting the broad application of HSCT for haematological malignancies. Cutaneous GvHD is described as a post-transplant inflammatory reaction by skin-infiltrating donor T cells and remaining recipient tissue-resident memory T cells. Despite the major influence of lymphocytes on GvHD pathogenesis, the complex role of mononuclear phagocytes (MNPs) in tissues affected by GvHD is increasingly appreciated. To characterize the identity, origin and functions of MNPs in patients with acute cutaneous GvHD. Using single-cell RNA sequencing and multiplex tissue immunofluorescence, we identified an increased abundance of MNPs in skin and blood from 36 patients with acute cutaneous GvHD. In cases of sex-mismatched transplantation, we used expression of X-linked genes to detect rapid tissue adaptation of newly recruited donor MNPs resulting in similar transcriptional states of host- and donor-derived macrophages within GvHD skin lesions. We showed that cutaneous GvHD lesions harbour expanded CD163+ tissue-resident macrophage populations with anti-inflammatory and tissue-remodelling properties including interleukin-10 cytokine production. Cell-cell interaction analyses revealed putative signalling to strengthen regulatory T-cell responses. Notably, macrophage polarization in chronic cutaneous GvHD types was proinflammatory and drastically differed from acute GvHD, supporting the notion of distinct cellular players in different clinical GvHD subtypes. Overall, our data reveal a surprisingly dynamic role of MNPs after HSCT. Specific and time-resolved targeting to repolarize this cell subset may present a promising therapeutic strategy in combatting GvHD skin inflammation.

Sections du résumé

BACKGROUND BACKGROUND
Graft-versus-host disease (GvHD) is a major life-threatening complication of allogeneic haematopoietic stem cell transplantation (HSCT), limiting the broad application of HSCT for haematological malignancies. Cutaneous GvHD is described as a post-transplant inflammatory reaction by skin-infiltrating donor T cells and remaining recipient tissue-resident memory T cells. Despite the major influence of lymphocytes on GvHD pathogenesis, the complex role of mononuclear phagocytes (MNPs) in tissues affected by GvHD is increasingly appreciated.
OBJECTIVES OBJECTIVE
To characterize the identity, origin and functions of MNPs in patients with acute cutaneous GvHD.
METHODS METHODS
Using single-cell RNA sequencing and multiplex tissue immunofluorescence, we identified an increased abundance of MNPs in skin and blood from 36 patients with acute cutaneous GvHD. In cases of sex-mismatched transplantation, we used expression of X-linked genes to detect rapid tissue adaptation of newly recruited donor MNPs resulting in similar transcriptional states of host- and donor-derived macrophages within GvHD skin lesions.
RESULTS RESULTS
We showed that cutaneous GvHD lesions harbour expanded CD163+ tissue-resident macrophage populations with anti-inflammatory and tissue-remodelling properties including interleukin-10 cytokine production. Cell-cell interaction analyses revealed putative signalling to strengthen regulatory T-cell responses. Notably, macrophage polarization in chronic cutaneous GvHD types was proinflammatory and drastically differed from acute GvHD, supporting the notion of distinct cellular players in different clinical GvHD subtypes.
CONCLUSIONS CONCLUSIONS
Overall, our data reveal a surprisingly dynamic role of MNPs after HSCT. Specific and time-resolved targeting to repolarize this cell subset may present a promising therapeutic strategy in combatting GvHD skin inflammation.

Identifiants

pubmed: 38010706
pii: 7451194
doi: 10.1093/bjd/ljad402
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
ID : 223092/Z/21/Z
Pays : United Kingdom

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of British Association of Dermatologists.

Déclaration de conflit d'intérêts

Conflicts of interest The authors declare no conflicts of interest related to this study.

Auteurs

Johanna Strobl (J)

Department of Dermatology, Medical University of Vienna, 1090 Vienna , Austria.
Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge , UK.
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna , Austria.

Laura M Gail (LM)

Department of Dermatology, Medical University of Vienna, 1090 Vienna , Austria.
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna , Austria.

Laura Krecu (L)

Department of Dermatology, Medical University of Vienna, 1090 Vienna , Austria.

Shaista Madad (S)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge , UK.
University of Cambridge, Cambridge , UK.

Lisa Kleissl (L)

Department of Dermatology, Medical University of Vienna, 1090 Vienna , Austria.
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna , Austria.

Luisa Unterluggauer (L)

Department of Dermatology, Medical University of Vienna, 1090 Vienna , Austria.

Anna Redl (A)

Department of Dermatology, Medical University of Vienna, 1090 Vienna , Austria.
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna , Austria.

Kveta Brazdilova (K)

Department of Dermatology, Medical University of Vienna, 1090 Vienna , Austria.
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna , Austria.

Simona Saluzzo (S)

Department of Dermatology, Medical University of Vienna, 1090 Vienna , Austria.

Philipp Wohlfarth (P)

Department of Internal Medicine I, Bone Marrow Transplantation Unit, Medical University of Vienna, 1090 Vienna , Austria.

Hanna A Knaus (HA)

Department of Internal Medicine I, Bone Marrow Transplantation Unit, Medical University of Vienna, 1090 Vienna , Austria.

Margit Mitterbauer (M)

Department of Internal Medicine I, Bone Marrow Transplantation Unit, Medical University of Vienna, 1090 Vienna , Austria.

Werner Rabitsch (W)

Department of Internal Medicine I, Bone Marrow Transplantation Unit, Medical University of Vienna, 1090 Vienna , Austria.

Muzlifah Haniffa (M)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge , UK.
Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne , UK.

Georg Stary (G)

Department of Dermatology, Medical University of Vienna, 1090 Vienna , Austria.
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna , Austria.

Classifications MeSH